Filtered By:
Management: Food and Drug Administration (FDA)
Procedure: Dialysis
This page shows you your search results in order of date.
Order by Relevance | Date
Total 42 results found since Jan 2013.
Osteoporosis Drug Increases Hypocalcemia Risk in Dialysis Patients
Am J Nurs. 2023 Mar 1;123(3):20. doi: 10.1097/01.NAJ.0000921788.03777.a2.ABSTRACTThe Food and Drug Administration has issued a Drug Safety Communication regarding the osteoporosis drug denosumab (Prolia). The communication warns of an increased risk of significant hypocalcemia with denosumab use in patients with advanced kidney disease, especially if they also receive dialysis.Nurses and NPs need to assess for hypocalcemia in patients with advanced kidney disease who receive denosumab. Patient education concerning the need for calcium and vitamin D supplements and repeated laboratory monitoring is crucial.PMID:36815815 | D...
Source: The American Journal of Nursing - February 23, 2023 Category: Nursing Authors: Diane S Aschenbrenner Source Type: research
